National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No.10) (No. PB 78 of 2011) (Cth)
PB 78 of 2011
National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No. 10)
National Health Act 1953
___________________________________________________________________________
I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated 25th October 2011
FELICITY MCNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No.10).
(2)This Instrument may also be cited as PB 78 of 2011.
2 Commencement
This Instrument commences on 1 November 2011.
3 Amendments to PB 117 of 2010
Schedule 1 amends the National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (PB 117 of 2010).
Schedule 1 Amendments
Schedule 1, entry for Fluorouracil in the form Injection 1000 mg in 20 mL
substitute:
| Injection 1000 mg in 20mL | Injection | DBL Fluorouracil Injection BP | HH | EMP | 5 | 0 |
| Fluorouracil Ebewe | SZ | EMP | 5 | 0 |
Schedule 1, entry for Fluorouracil in the form Injection 2500 mg in 50 mL
substitute:
| Injection 2500 mg in 50 mL | Injection | DBL Fluorouracil Injection BP | HH | EMP | 2 | 0 |
| Fluorouracil Ebewe | SZ | EMP | 2 | 0 |
Schedule 1, entry for Irinotecan in the form I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL
substitute:
| I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Hospira Pty Limited | HH | EMP | C3184 | 1 | 3 |
| Irinotecan Actavis 500 | TA | EMP | C3184 | 1 | 3 | ||
| Irinotecan Ebewe | SZ | EMP | C3184 | 1 | 3 |
Schedule 1, entry for Methotrexate in the form Injection 50 mg in 2 mL vial, in the column headed ‘Number of Repeats’
Omit (all instances):
0
substitute:
5
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0